Back to Stock Universe
Daily Decision Engine
GLAXOSMITHKLINEPHARM
Glaxosmithkline Pharmaceuticals Ltd. · Healthcare · Branded Medicines · Mid Cap
HOLD with net score +3 (+7 buy, −4 sell). Strongest positive: P/E Below Its 5Y Median (weight 2). 5 BUY rules fire total. Caution: Stretched EV/EBITDA (weight 2) flags risk. P/E is 23% below its 5Y median — historically cheap.
Engine Verdict
Hold
Score
+3
Buy
+7
Sell
−4
Veto
—
Price Context
Current Price
₹2,354.80
1M
+2.08%
1Y
-27.08%
3Y
+18.51%
5Y
+9.19%
52W Low ₹2,088.10Now ₹2,354.8052W High ₹3,500.00
Price History (Yahoo) with Your Decisions
No price data returned for this ticker.
Returns Profile
VR Score Radar (out of 10)
Verdict Breakdown · 7 triggered / 21 active
P/E Below Its 5Y MedianBUYw2
P/E vs Median % < 0 → -22.98
P/B Below Its 5Y MedianBUYw2
P/B vs Median % < 0 → -13.52
Healthy Pullback EntryBUYw1
% off 52W High ≥ 15 → 32.72
Bottom-fishing SetupBUYw1
% above 52W Low ≤ 20 → 12.77VR Quality Score (1-10) ≥ 8 → 10.00
Solid DividendBUYw1
Dividend Yield % ≥ 2 → 2.43
Stretched EV/EBITDASELLw2
EV / EBITDA > 25 → 26.42
Overpaying for GrowthSELLw2
Price / Sales > 10 → 10.42VR Growth Score (1-10) < 7 → 6.00
VR Stock Rating StrongBUYw4
VR Stock Rating (1-5) ≥ 4 → 3.00
Failed: VR Stock Rating (1-5) = 3.00 is not ≥ 4.
VR Valuation Score StrongBUYw2
VR Valuation Score (1-10) ≥ 6 → 5.00
Failed: VR Valuation Score (1-10) = 5.00 is not ≥ 6.
Cheap on EV/EBITDABUYw2
EV / EBITDA < 12 → 26.42
Failed: EV / EBITDA = 26.42 is not < 12.
Cheap on Cash FlowBUYw2
Price / CFO < 15 → 44.08
Failed: Price / CFO = 44.08 is not < 15.
VR Proprietary Scores
VR Stock Rating
3 / 5 ⭐
Quality
10/10
Growth
6/10
Valuation
5/10
Momentum
1/10
Fundamentals
P/E
38.44
vs 5Y median 49.90 · -23.0%
P/B
17.44
vs 5Y median 20.17 · -13.5%
EV/EBITDA
26.42
Price / CFO
44.08
Price / Sales
10.42
PEG
1.87
From VR
Earning Yield %
3.36
From VR
Dividend Yield %
2.43
FCF / Share
46.19
→ FCF Yield 1.96%
EPS
60.26
Market Cap
39818.89 Cr
Enterprise Value
37104.67 Cr
Engine Zone Timeline · 2 runs
06-25+3
06-26+3
STRONG BUY
BUY
HOLD
SELL
STRONG SELL
AVOID
Your Decisions on GLAXOSMITHKLINEPHARM · 0
No decisions logged on this stock yet.
Use “Log Decision” above to start your trade journal. Every decision will appear here with hindsight grade.
Position Lifecycle · GLAXOSMITHKLINEPHARM
No position taken yet
You've only WATCHED / SKIPPED so far. Log a BUY decision to begin the lifecycle.
Recent News · GLAXOSMITHKLINEPHARM
No recent news found
Yahoo Finance returned no headlines for ticker GLAXOSMITHKLINEPHARM.NS.
If this ticker looks wrong (e.g. should be INFY.NS not INFOSYS.NS), open Symbol Aliases and set the correct Yahoo ticker.
Sector Peers
Comparing against 4 peers matched by industry: Branded Medicines
| Stock | Zone | Price | Mcap | P/E | P/B | ROE % | ROCE % | D/E | EPS g% | Div Y% | 1Y Ret % | Quality |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GLAXOSMITHKLINEPHARMYOU Glaxosmithkline Pharmaceuticals Ltd. | Hold | 2,354.80 | ₹398B | 38.44 | 17.44 | — | — | — | — | 2.43 | -27.08 | 10/10 |
| SUNPHARMACEUTICALIND Sun Pharmaceutical Industries Ltd. | Buy | 1,862.80 | ₹4.48T | 39.00 | 5.36 | — | — | — | — | 0.86 | 12.10 | 8/10 |
| CIPLA Cipla Ltd. | Hold | 1,440.10 | ₹1.17T | 30.18 | 3.41 | — | — | — | — | 0.90 | -4.15 | 8/10 |
| ZYDUSLIFESCIENCES Zydus Lifesciences Ltd. | Buy | 1,101.40 | ₹1.10T | 21.83 | 4.23 | — | — | — | — | 0.09 | 14.19 | 9/10 |
| AJANTAPHARMA Ajanta Pharma Ltd. | Hold | 3,180.40 | ₹398B | 37.68 | 8.80 | — | — | — | — | 0.88 | 24.03 | 7/10 |
Green = peer is better than you on that metric (lower for valuation, higher for quality/growth). Click any peer to deep-dive.
AI Deep Dive (Claude)
Daily quota: 0 / 5
No AI analysis yet
Click 'Generate' to have Claude write a bull-case / bear-case / verdict-flip analysis using all the data on this page.
Ask Claude about this stock
Discuss GLAXOSMITHKLINEPHARM with AI0/30 today
Ask anything about GLAXOSMITHKLINEPHARM
I have your fundamentals, all 21 rule evaluations, recent analysis, and your decision journal in context.